The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells

FASEB Journal

Volumn 29, Issue 4, 2015, Pages 1371-1382

  Jia, Di ^a,b   Huang, Lan ^a,b   Bischoff, Joyce ^a,b   Moses, Marsha A ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Repression; Transcriptional regulation; VEGF

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE 14; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; ZINC FINGER TRANSCRIPTION FACTOR 24; KRUPPEL LIKE FACTOR; MESSENGER RNA; MMP2 PROTEIN, HUMAN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2, HUMAN; ZNF24 PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL COMPARTMENTALIZATION; CELL CYCLE REGULATION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; CYTOLOGY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PHYSIOLOGIC; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84931355386     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-258947     Document Type: Article

References (60)

1. Han, Z. G., Zhang, Q. H., Ye, M., Kan, L. X., Gu, B. W., He, K. L., Shi, S. L., Zhou, J., Fu, G., Mao, M., Chen, S. J., Yu, L., and Chen, Z. (1999) Molecular cloning of six novel Krüppel-like zinc finger genes from hematopoietic cells and identification of a novel transregulatory domain KRNB. J. Biol. Chem. 274, 35741-35748
2. Wang, H., Sun, R., Liu, G., Yao, M., Fei, J., and Shen, H. (2008) Characterization of the target DNA sequence for the DNA-binding domain of zinc finger protein 191. Acta Biochim. Biophys. Sin. (Shanghai) 40, 704-710
3. Edelstein, L. C., and Collins, T. (2005) The SCAN domain family of zinc finger transcription factors. Gene 359, 1-17
4. Khalfallah, O., Faucon-Biguet, N., Nardelli, J., Meloni, R., and Mallet, J. (2008) Expression of the transcription factor Zfp191 during embryonic development in the mouse. Gene Expr. Patterns 8, 148-154
5. Prost, J. F., Nègre, D., Cornet-Javaux, F., Cortay, J. C., Cozzone, A. J., Herbage, D., and Mallein-Gerin, F. (1999) Isolation, cloning, and expression of a new murine zinc finger encoding gene. Biochim. Biophys. Acta 1447, 278-283
6. Howng, S. Y., Avila, R. L., Emery, B., Traka, M., Lin, W., Watkins, T., Cook, S., Bronson, R., Davisson, M., Barres, B. A., and Popko, B. (2010) ZFP191 is required by oligodendrocytes for CNS myelination. Genes Dev. 24, 301-311
7. Li, J., Chen, X., Yang, H., Wang, S., Guo, B., Yu, L., Wang, Z., and Fu, J. (2006) The zinc finger transcription factor 191 is required for early embryonic development and cell proliferation. Exp. Cell Res. 312, 3990-3998
8. Khalfallah, O., Ravassard, P., Lagache, C. S., Fligny, C., Serre, A., Bayard, E., Faucon-Biguet, N., Mallet, J., Meloni, R., and Nardelli, J. (2009) Zinc finger protein 191 (ZNF191/Zfp191) is necessary to maintain neural cells as cycling progenitors. Stem Cells 27, 1643-1653
9. Lv, L., Zhang, J., Wang, P., Meng, Q., Liang, W., and Zhang, L. (2014) Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury. J. Vasc. Surg. 59, 500-509
10. Harper, J., Yan, L., Loureiro, R. M., Wu, I., Fang, J., D'Amore, P. A., and Moses, M. A. (2007) Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24. Cancer Res. 67, 8736-8741
11. Jia, D., Hasso, S. M., Chan, J., Filingeri, D., D'Amore, P. A., Rice, L., Pampo, C., Siemann, D. W., Zurakowski, D., Rodig, S. J., and Moses, M. A. (2013) Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo. Blood 121, 707-715
12. Liu, G., Jiang, S., Wang, C., Jiang, W., Liu, Z., Liu, C., Saiyin, H., Yang, X., Shen, S., Jiang, D., Zhou, P., Han, D., Hu, X., Yi, Q., and Yu, L. (2012) Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma. Hepatology 55, 1830-1839
13. Harper, J., and Moses, M. A. (2006) Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications. EXS (96), 223-268
14. Melero-Martin, J. M., De Obaldia, M. E., Kang, S. Y., Khan, Z. A., Yuan, L., Oettgen, P., and Bischoff, J. (2008) Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ. Res. 103, 194-202
15. Smith, E. R., Zurakowski, D., Saad, A., Scott, R. M., and Moses, M. A. (2008) Urinary biomarkers predict brain tumor presence and response to therapy. Clin. Cancer Res. 14, 2378-2386
16. Fernández, C. A., and Moses, M. A. (2006) Modulation of angiogenesis by tissue inhibitor of metalloproteinase-4. Biochem. Biophys. Res. Commun. 345, 523-529
17. Roy, R., Rodig, S., Bielenberg, D., Zurakowski, D., and Moses, M. A. (2011) ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis. J. Biol. Chem. 286, 20758-20768
18. Yang, J., McNeish, B., Butterfield, C., and Moses, M. A. (2013) Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer. FASEB J. 27, 45-50
19. Yang, J., Bielenberg, D. R., Rodig, S. J., Doiron, R., Clifton, M. C., Kung, A. L., Strong, R. K., Zurakowski, D., and Moses, M. A. (2009) Lipocalin 2 promotes breast cancer progression. Proc. Natl. Acad. Sci. USA 106, 3913-3918
20. Fernandez, C. A., Roy, R., Lee, S., Yang, J., Panigrahy, D., Van Vliet, K. J., and Moses, M. A. (2010) The anti-angiogenic peptide, loop 6, binds insulin-like growth factor-1 receptor. J. Biol. Chem. 285, 41886-41895
21. Roy, R., and Moses, M. A. (2012) ADAM12 induces estrogen-independence in breast cancer cells. Breast Cancer Res. Treat. 131, 731-741
22. Foradori, M. J., Chen, Q., Fernandez, C. A., Harper, J., Li, X., Tsang, P. C., Langer, R., and Moses, M. A. (2014) Matrilin-1 is an inhibitor of neovascularization. J. Biol. Chem. 289, 14301-14309
23. Moses, M. A., Wiederschain, D., Loughlin, K. R., Zurakowski, D., Lamb, C. C., and Freeman, M. R. (1998) Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res. 58, 1395-1399
24. Fernández, C. A., Yan, L., Louis, G., Yang, J., Kutok, J. L., and Moses, M. A. (2005) The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin. Cancer Res. 11, 5390-5395
25. Pories, S. E., Zurakowski, D., Roy, R., Lamb, C. C., Raza, S., Exarhopoulos, A., Scheib, R. G., Schumer, S., Lenahan, C., Borges, V., Louis, G. W., Anand, A., Isakovich, N., Hirshfield-Bartek, J., Wewer, U., Lotz, M. M., and Moses, M. A. (2008) Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment. Cancer Epidemiol. Biomarkers Prev. 17, 1034-1042
26. Coticchia, C. M., Curatolo, A. S., Zurakowski, D., Yang, J., Daniels, K. E., Matulonis, U. A., and Moses, M. A. (2011) Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels. Gynecol. Oncol. 123, 295-300
27. Roy, R., Louis, G., Loughlin, K. R., Wiederschain, D., Kilroy, S. M., Lamb, C. C., Zurakowski, D., and Moses, M. A. (2008) Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species. Clin. Cancer Res. 14, 6610-6617
28. Herron, G. S., Werb, Z., Dwyer, K., and Banda, M. J. (1986) Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem. 261, 2810-2813
29. Moses, M. A., Sudhalter, J., and Langer, R. (1990) Identification of an inhibitor of neovascularization from cartilage. Science 248, 1408-1410
30. Fernández, C. A., Butterfield, C., Jackson, G., and Moses, M. A. (2003) Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor. J. Biol. Chem. 278, 40989-40995
31. Roy, R., Zhang, B., and Moses, M. A. (2006) Making the cut: protease-mediated regulation of angiogenesis. Exp. Cell Res. 312, 608-622
32. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., and Goldberg, G. I. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270, 5331-5338
33. Stetler-Stevenson, W. G., Krutzsch, H. C., Wacher, M. P., Margulies, I. M., and Liotta, L. A. (1989) The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J. Biol. Chem. 264, 1353-1356
34. Van Wart, H. E., and Birkedal-Hansen, H. (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87, 5578-5582
35. Emmert-Buck, M. R., Emonard, H. P., Corcoran, M. L., Krutzsch, H. C., Foidart, J. M., and Stetler-Stevenson, W. G. (1995) Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex. FEBS Lett. 364, 28-32
36. Théret, N., Lehti, K., Musso, O., and Clément, B. (1999) MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells. Hepatology 30, 462-468
37. Stanton, H., Gavrilovic, J., Atkinson, S. J., d'Ortho, M. P., Yamada, K. M., Zardi, L., and Murphy, G. (1998) The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J. Cell Sci. 111, 2789-2798
38. Lozito, T. P., Jackson, W. M., Nesti, L. J., and Tuan, R. S. (2014) Human mesenchymal stem cells generate a distinct pericellular zone of MMP activities via binding of MMPs and secretion of high levels of TIMPs. Matrix Biol. 34, 132-143
39. Chi, J. T., Chang, H. Y., Haraldsen, G., Jahnsen, F. L., Troyanskaya, O. G., Chang, D. S., Wang, Z., Rockson, S. G., van de Rijn, M., Botstein, D., and Brown, P. O. (2003) Endothelial cell diversity revealed by global expression profiling. Proc. Natl. Acad. Sci. USA 100, 10623-10628
40. Dib, H., Chafey, P., Clary, G., Federici, C., Le Gall, M., Dwyer, J., Gavard, J., Tamas, N., Bussone, G., Broussard, C., Camoin, L., Witko-Sarsat, V., Tamby, M. C., and Mouthon, L. (2012) Proteomes of umbilical vein and microvascular endothelial cells reflect distinct biological properties and influence immune recognition. Proteomics 12, 2547-2555
41. Bouchard, C., Thieke, K., Maier, A., Saffrich, R., Hanley-Hyde, J., Ansorge, W., Reed, S., Sicinski, P., Bartek, J., and Eilers, M. (1999) Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18, 5321-5333
42. Gyuris, J., Golemis, E., Chertkov, H., and Brent, R. (1993) Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75, 791-803
43. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439
44. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66
45. Itoh, T., Ikeda, T., Gomi, H., Nakao, S., Suzuki, T., and Itohara, S. (1997) Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 272, 22389-22392
46. Ohno-Matsui, K., Uetama, T., Yoshida, T., Hayano, M., Itoh, T., Morita, I., and Mochizuki, M. (2003) Reduced retinal angiogenesis in MMP-2-deficient mice. Invest. Ophthalmol. Vis. Sci. 44, 5370-5375
47. Hofmann, J. J., and Iruela-Arispe, M. L. (2007) Notch signaling in blood vessels: who is talking to whom about what? Circ. Res. 100, 1556-1568
48. Bozkulak, E. C., and Weinmaster, G. (2009) Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol. Cell. Biol. 29, 5679-5695
49. Aird, W. C. (2012) Endothelial cell heterogeneity. Cold Spring Harb Perspect Med 2, a006429
50. Ma, Y., Li, A., Faller, W. J., Libertini, S., Fiorito, F., Gillespie, D. A., Sansom, O. J., Yamashiro, S., and Machesky, L. M. (2013) Fascin 1 is transiently expressed in mouse melanoblasts during development and promotes migration and proliferation. Development 140, 2203-2211
51. Xie, J. J., Xu, L. Y., Zhang, H. H., Cai, W. J., Mai, R. Q., Xie, Y. M., Yang, Z. M., Niu, Y. D., Shen, Z. Y., and Li, E. M. (2005) Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem. Biophys. Res. Commun. 337, 355-362
52. Labrecque, L., Royal, I., Surprenant, D. S., Patterson, C., Gingras, D., and Béliveau, R. (2003) Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol. Biol. Cell 14, 334-347
53. Noghero, A., Perino, A., Seano, G., Saglio, E., Lo Sasso, G., Veglio, F., Primo, L., Hirsch, E., Bussolino, F., and Morello, F. (2012) Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2. Arterioscler. Thromb. Vasc. Biol. 32, 2280-2288
54. Fang, L., Choi, S. H., Baek, J. S., Liu, C., Almazan, F., Ulrich, F., Wiesner, P., Taleb, A., Deer, E., Pattison, J., Torres-Vázquez, J., Li, A. C., and Miller, Y. I. (2013) Control of angiogenesis by AIBP-mediated cholesterol efflux. Nature 498, 118-122
55. Arvey, A., Agius, P., Noble, W. S., and Leslie, C. (2012) Sequence and chromatin determinants of cell-type-specific transcription factor binding. Genome Res. 22, 1723-1734
56. Hutchins, A. P., Diez, D., Takahashi, Y., Ahmad, S., Jauch, R., Tremblay, M. L., and Miranda-Saavedra, D. (2013) Distinct transcriptional regulatory modules underlie STAT3's cell type-independent and cell type-specific functions. Nucleic Acids Res. 41, 2155-2170
57. Albanèse, V., Biguet, N. F., Kiefer, H., Bayard, E., Mallet, J., and Meloni, R. (2001) Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. Hum. Mol. Genet. 10, 1785-1792
58. Rodrigues, M., Xin, X., Jee, K., Babapoor-Farrokhran, S., Kashiwabuchi, F., Ma, T., Bhutto, I., Hassan, S. J., Daoud, Y., Baranano, D., Solomon, S., Lutty, G., Semenza, G. L., Montaner, S., and Sodhi, A. (2013) VEGF secreted by hypoxic Müller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy. Diabetes 62, 3863-3873
59. Sanda, T., Li, X., Gutierrez, A., Ahn, Y., Neuberg, D. S., O'Neil, J., Strack, P. R., Winter, C. G., Winter, S. S., Larson, R. S., von Boehmer, H., and Look, A. T. (2010) Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia. Blood 115, 1735-1745
60. Palomero, T., Lim, W. K., Odom, D. T., Sulis, M. L., Real, P. J., Margolin, A., Barnes, K. C., O'Neil, J., Neuberg, D., Weng, A. P., Aster, J. C., Sigaux, F., Soulier, J., Look, A. T., Young, R. A., Califano, A., and Ferrando, A. A. (2006) NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc. Natl. Acad. Sci. USA 103, 18261-18266